Wedge Capital Management L L P NC Has $31.23 Million Position in CVS Health Corporation $CVS

Key Points

• Wedge Capital Management cut its CVS Health position by 16.2% in the second quarter, selling 58,261 shares and retaining 301,882 shares valued at approximately $31.23 million. Institutional investors collectively own 80.66% of CVS stock.
• CVS Health reported stronger-than-expected quarterly results, with earnings of $2.58 per share versus the $1.87 consensus estimate and revenue of $106.1 billion, up 7.3% year over year. The company issued fiscal 2026 EPS guidance of $7.90–$8.10.
• Analysts maintain a generally positive view, with 22 Buy ratings and two Holds, producing a “Moderate Buy” consensus and an average price target of $106.46. CVS also pays a quarterly dividend of $0.665, equivalent to a 2.8% annual yield.

Wedge Capital Management L L P NC decreased its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 16.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 301,882 shares of the pharmacy operator's stock after selling 58,261 shares during the quarter. Wedge Capital Management L L P NC's holdings in CVS Health were worth $31,230,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Annex Advisory Services LLC boosted its holdings in CVS Health by 5.7% during the second quarter. Annex Advisory Services LLC now owns 6,867 shares of the pharmacy operator's stock valued at $710,000 after purchasing an additional 368 shares in the last quarter. Tema ETFs LLC raised its holdings in shares of CVS Health by 10.5% in the 2nd quarter. Tema ETFs LLC now owns 22,903 shares of the pharmacy operator's stock worth $2,369,000 after buying an additional 2,175 shares in the last quarter. West Branch Capital LLC lifted its position in shares of CVS Health by 28.1% during the 2nd quarter. West Branch Capital LLC now owns 756 shares of the pharmacy operator's stock worth $78,000 after buying an additional 166 shares during the period. Yoffe Investment Management LLC acquired a new stake in CVS Health in the 2nd quarter valued at $213,000. Finally, Generali Investments Management Co LLC grew its position in CVS Health by 35.6% in the second quarter. Generali Investments Management Co LLC now owns 9,330 shares of the pharmacy operator's stock valued at $965,000 after acquiring an additional 2,452 shares during the period. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 2.4%

Shares of NYSE CVS opened at $93.41 on Wednesday. CVS Health Corporation has a 12-month low of $64.32 and a 12-month high of $110.68. The firm's 50-day simple moving average is $102.43 and its 200 day simple moving average is $88.00. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The company has a market cap of $119.47 billion, a price-to-earnings ratio of 24.71, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the previous year, the firm posted $1.81 earnings per share. The company's revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health's payout ratio is 70.37%.

Analyst Ratings Changes

CVS has been the subject of several recent analyst reports. Morgan Stanley increased their price objective on CVS Health from $106.00 to $111.00 and gave the stock an "overweight" rating in a research note on Thursday, June 4th. Argus upped their target price on shares of CVS Health from $90.00 to $104.00 and gave the stock a "buy" rating in a report on Thursday, May 14th. TD Cowen increased their target price on shares of CVS Health from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, May 11th. Mizuho boosted their price target on shares of CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a research report on Monday, June 8th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of CVS Health from $88.00 to $92.00 and gave the stock a "buy" rating in a research note on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $106.46.

Insider Transactions at CVS Health

In other CVS Health news, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total value of $187,345,164.10. Following the transaction, the director directly owned 6,213,261 shares in the company, valued at approximately $586,842,501.45. This trade represents a 24.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last 90 days, insiders sold 3,372,000 shares of company stock worth $317,473,598. 0.85% of the stock is currently owned by corporate insiders.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source